ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.23%
S&P ASX All Technology
2,972.40
0.12%
Brent Oil
83.495
-0.05%
US Dollar vs AUD
1.52856
-0.16%
Bitcoin
58,622.80
0.66%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Merrimack Pharmaceuticals Inc (MACK)

  7. Merrimack Pharmaceuticals Inc (MACK) News

MACK Merrimack Pharmaceuticals Inc

15.00
0.02 (0.13%)
Pre Market
Last Updated: 22:17:32
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Merrimack Pharmaceuticals Inc MACK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.02 0.13% 15.00 22:17:32
Open Price Low Price High Price Close Price Previous Close
14.98
more quote information »

Recent News

Date Time Source Heading
01/5/202407:15BWMerrimack Pharmaceuticals Announces Notification of Plan to..
28/3/202407:30BWMerrimack Receives $225 Million Milestone Payment from Ipsen
08/3/202408:42EDGAR2Form 425 - Prospectuses and communications, business..
08/3/202408:39EDGAR2Form 8-K - Current report
08/3/202408:30BWMerrimack Reports Full Year 2023 Financial Results
08/3/202408:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202404:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/3/202408:44EDGAR2Form PRE 14A - Other preliminary proxy statements
15/2/202408:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/2/202408:22EDGAR2Form 8-K - Current report
14/2/202408:18BWMerrimack Reports Ipsen Announcement of Approval By The US..
26/1/202408:05EDGAR2Form SC 13D/A - General statement of acquisition of..
29/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202308:05EDGAR2Form SC 13D/A - General statement of acquisition of..
12/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202310:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202309:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:30BWMerrimack Reports Third Quarter 2023 Financial Results
15/8/202306:05EDGAR2Form SC 13D/A - General statement of acquisition of..
10/8/202306:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:36EDGAR2Form 8-K - Current report
04/8/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:30BWMerrimack Reports Second Quarter 2023 Financial Results
05/5/202307:00BW Merrimack Reports First Quarter 2023 Financial Results

Your Recent History

NASDAQ
MACK
Merrimack Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved